Skip to search formSkip to main content

bortezomib/SCIO-469

Known as: PS-341/SCIO 469 
 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2004
2004
 
Is this relevant?
Review
2004
Review
2004
SCIO-469 is a small-molecule p38 mitogen-activated protein (MAP) kinase inhibitor under development by Scios Inc as a potential… Expand
Is this relevant?